Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant

Figure 2 Post-liver transplant 3-year risk of recurrence, overall mortality, and recurrence-free survival in patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma compared with patients with hepatocellular carcinoma, matched 1:8 for pretransplant tumor characteristics (Pre liver transplant characteristics) and pathologic tumor characteristics (Post liver transplant characteristics). ^aPre liver transplant (LT) characteristics: serum alpha-fetoprotein and radiologic tumor diameter; ^bPost LT characteristics: Tumor diameter, grade/differentiation, microvascular invasion. PSM: Propensity score matching; LT: Liver transplant; HCC: Hepatocellular carcinoma; HCC-CC: Hepatocellular cholangiocarcinoma; ICC: Intrahepatic cholangiocarcinoma.